Is there a place for 'immuno' in the immunotherapy of multiple sclerosis?
Forsthuber
Thomas G
TG
Muraro
Paolo
P
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000276:immunology; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy*; D004676:Myelin Basic Protein / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D016207:Cytokines; D004676:Myelin Basic Protein; D010446:Peptide Fragments